Sanegene Bio
PrivateLast Round
Series B
Dec 8, 2025
Total Funding Raised
$228M
Momentum Score
25 /100
Company Overview
Sanegene Bio is a biotechnology company that develops RNA interference (RNAi) therapeutics for obesity, cardiometabolic, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanegene Bio Comps
Public and private peers based on sector, stage, and business model.
Sanegene Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 8, 2025 | ||||
| Strategic | Nov 8, 2025 | ||||
| Series A Extension | Dec 1, 2023 | ||||
| Series A | Aug 31, 2021 |
Key People
Founding team and executive leadership
Sanegene Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A Extension, Series A |
| SymBiosis Capital Management | Series B |
| Lake Bleu Capital | Series B |
| Shanghai Healthcare Capital | Series A Extension |
| Oriza Holdings | Series B, Series A Extension |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Series A Extension |
| TF Capital | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Partnered with Genentech to advance RNAi programs.
- Dec 8, 2025
$110M round raised
Sanegene Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sanegene Bio's valuation, stock price, and market status.
